DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Companies / Strand Therapeutics Inc.
Strand Therapeutics Inc.
Stage unknownBoston, MABiotechnology
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- Decline to Disclosesec.gov
- Rounds on record
- 1
- Disclosed raised
- unknownsum of rounds with a disclosed amount only
- Named investors
- 1
Financing history
1 rounds
- May 23, 2025Form D equity offering · $108M (form d sold) · 10 investorsFact SEC EDGAR Form D data sets (quarterly) · “Strand Therapeutics Inc. filed Form D: $108,099,927 sold of $120,099,940, Biotechnology”
Investors on record
1 edges
- FPV Management, LLC board only, Pegah Ebrahimi (strongly supported) Inference sec.gov
People
3 officers, 5 directors
- Jacob Becraft Executive Officer/Director/Promoter sec.gov
- Samta Kundu Executive Officer sec.gov
- Tasuku Kitada Executive Officer/Director/Promoter sec.gov
- Jory Bell Director Fact
- JEB Keiper Director Fact
- ALA Alenazi Director Fact
- Pegah Ebrahimi Director Fact
- Pegah Ebrahimi Director Inference
Timeline
1
- Mar 17, 2026Strand Therapeutics Inc. filed Form D: $108,099,927 sold of $120,099,940, BiotechnologyForm D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
14 observations
Every observation on this company
- Entity type: Corporation Mar 17, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Biotechnology Mar 17, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: false Mar 17, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): Decline to Disclose Mar 17, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: overFiveYears Mar 17, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE Mar 17, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $108M Mar 17, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Offering amount (Form D): $120M Mar 17, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06b Mar 17, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- First sale: 2025-05-23 Mar 17, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 10 Mar 17, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 0 Mar 17, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Securities offered: equity Mar 17, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: 20 Overland Street, Suite A, Boston, MA, 02215 Mar 17, 2026 Fact SEC EDGAR Form D data sets (quarterly)